Proteomic analysis and identification of aqueous humor proteins with a pathophysiological role in diabetic retinopathy

Journal of Proteomics

Volumn 75, Issue 10, 2012, Pages 2950-2959

  Chiang, Shang Yi ^a,b   Tsai, Ming Ling ^b   Wang, Chih Yuan ^c   Chen, Ann ^b   Chou, Yu Ching ^a   Hsia, Ching Wu ^a   Wu, Yung Fu ^b   Chen, Han Min ^d   Huang, Tzu Hao ^e   Chen, Pei Hsiu ^a   Liu, Hung Te ^a   Shui, Hao Ai ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^e CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Aqueous humor; Biomarkers; Pathophysiology; Proteomics; Retinopathy; Susceptibility factors

Indexed keywords

APOLIPOPROTEIN A1; BRAIN SPECIFIC ANGIOGENESIS INHIBITOR 1 ASSOCIATED PROTEIN 2; COLLAGENASE 3; CYSTATHIONINE BETA SYNTHASE; GROWTH FACTOR RECEPTOR BOUND PROTEIN 10; KERATIN TYPE I CYTOSKELETAL 10 PROTEIN; KERATIN TYPE I CYTOSKELETAL 9 PROTEIN; PODOCAN; PROTEIN; RETROTRANSPOSON GAG DOMAIN CONTAINING PROTEIN 1; SELENOPROTEIN P; TRANSFERRIN; UNCLASSIFIED DRUG;

ADULT; AGED; AQUEOUS HUMOR; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; HUMAN; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NEUROPROTECTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; RISK FACTOR; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; AQUEOUS HUMOR; CASE-CONTROL STUDIES; DIABETIC RETINOPATHY; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; EYE PROTEINS; HUMANS; METABOLIC NETWORKS AND PATHWAYS; MIDDLE AGED; MODELS, BIOLOGICAL; OSMOLAR CONCENTRATION; PROTEOME; PROTEOMICS; VALIDATION STUDIES AS TOPIC;

EID: 84862788359     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2011.12.006     Document Type: Article

References (63)

1. Priem H.A. Diabetes mellitus and the eye. Acta Clin Belg 2004, 59:237-240.
2. Negi A., Vernon S.A. An overview of the eye in diabetes. J R Soc Med 2003, 96:266-272.
3. Grus F.H., Joachim S.C., Pfeiffer N. Proteomics in ocular fluids. Proteomics Clin Appl 2007, 1:876-888.
4. Herber S., Grus F.H., Sabuncuo P., Augustin A.J. Two-dimensional analysis of tear protein patterns of diabetic patients. Electrophoresis 2001, 22:1838-1844.
5. Grus F.H., Sabuncuo P., Dick H.B., Augustin A.J., Pfeiffer N. Changes in the tear proteins of diabetic patients. BMC Ophthalmol 2002, 2:4.
6. Grus F.H., Sabuncuo P., Augustin A.J. Analysis of tear protein patterns of dry-eye patients using fluorescent staining dyes and two-dimensional quantification algorithms. Electrophoresis 2001, 22:1845-1850.
7. Er H., Doganay S., Ozerol E., Yurekli M. Adrenomedullin and leptin levels in diabetic retinopathy and retinal diseases. Ophthalmologica 2005, 219:107-111.
8. Murugeswari P., Shukla D., Rajendran A., Kim R., Namperumalsamy P., Muthukkaruppan V. Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease. Retina 2008, 28:817-824.
9. Roldan-Pallares M., Rollin R., Martinez-Montero J.C., Fernandez-Cruz A., Bravo-Llata C., Fernandez-Durango R. Immunoreactive endothelin-1 in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy. Retina 2007, 27:222-235.
10. Funatsu H., Yamashita H., Sakata K., Noma H., Mimura T., Suzuki M., et al. Vitreous levels of vascular endothelial growth factor and intercellular adhesion molecule 1 are related to diabetic macular edema. Ophthalmology 2005, 112:806-816.
11. Funatsu H., Yamashita H., Noma H., Mimura T., Nakamura S., Sakata K., et al. Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients. Graefes Arch Clin Exp Ophthalmol 2005, 243:3-8.
12. Jonas J.B., Neumaier M. Erythropoietin levels in aqueous humour in eyes with exudative age-related macular degeneration and diabetic retinopathy. Clin Experiment Ophthalmol 2007, 35:186-187.
13. Shinoda K., Ishida S., Kawashima S., Wakabayashi T., Matsuzaki T., Takayama M., et al. Comparison of the levels of hepatocyte growth factor and vascular endothelial growth factor in aqueous fluid and serum with grades of retinopathy in patients with diabetes mellitus. Br J Ophthalmol 1999, 83:834-837.
14. Tashimo A., Mitamura Y., Nagai S., Nakamura Y., Ohtsuka K., Mizue Y., et al. Aqueous levels of macrophage migration inhibitory factor and monocyte chemotactic protein-1 in patients with diabetic retinopathy. Diabet Med 2004, 21:1292-1297.
15. Duan X., Xue P., Wang N., Dong Z., Lu Q., Yang F. Proteomic analysis of aqueous humor from patients with primary open angle glaucoma. Mol Vis 2010, 16:2839-2846.
16. Missotten G.S., Beijnen J.H., Keunen J.E., Bonfrer J.M. Proteomics in uveal melanoma. Melanoma Res 2003, 13:627-629.
17. Izzotti A., Longobardi M.G., Cartiglia C., Sacca S.C. Proteome alterations in primary open angle glaucoma aqueous humour. J Proteome Res 2010, 9:4831-4838.
18. Duan X., Lu Q., Xue P., Zhang H., Dong Z., Yang F., et al. Proteomic analysis of aqueous humor from patients with myopia. Mol Vis 2008, 14:370-377.
19. Grus F.H., Joachim S.C., Sandmann S., Thiel U., Bruns K., Lackner K.J., et al. Transthyretin and complex protein pattern in aqueous humor of patients with primary open-angle glaucoma. Mol Vis 2008, 14:1437-1445.
20. Funding M., Vorum H., Honore B., Nexo E., Ehlers N. Proteomic analysis of aqueous humour from patients with acute corneal rejection. Acta Ophthalmol Scand 2005, 83:31-39.
21. Madsen-Bouterse S.A., Kowluru R.A. Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives. Rev Endocr Metab Disord 2008, 9:315-327.
22. Cheung N., Mitchell P., Wong T.Y. Diabetic retinopathy. Lancet 2010, 376:124-136.
23. Adamis A.P., Berman A.J. Immunological mechanisms in the pathogenesis of diabetic retinopathy. Semin Immunopathol 2008, 30:65-84.
24. Zhang X., Bao S., Hambly B.D., Gillies M.C. Vascular endothelial growth factor-A: a multifunctional molecular player in diabetic retinopathy. Int J Biochem Cell Biol 2009, 41:2368-2371.
25. Endo H., Naito T., Asahara T., Kajima M., Shiota H. Cytokines in the vitreous fluid of patients with proliferative diabetic retinopathy-vascular endothelial growth factor and platelet-derived growth factor are elevated in proliferative diabetic retinopathy. Nippon Ganka Gakkai Zasshi 2000, 104:711-716.
26. Grierson I., Heathcote L., Hiscott P., Hogg P., Briggs M., Hagan S. Hepatocyte growth factor/scatter factor in the eye. Prog Retin Eye Res 2000, 19:779-802.
27. Fort P.E., Freeman W.M., Losiewicz M.K., Singh R.S., Gardner T.W. The retinal proteome in experimental diabetic retinopathy: up-regulation of crystallins and reversal by systemic and periocular insulin. Mol Cell Proteomics 2009, 8:767-779.
28. Gao B.B., Phipps J.A., Bursell D., Clermont A.C., Feener E.P. Angiotensin AT1 receptor antagonism ameliorates murine retinal proteome changes induced by diabetes. J Proteome Res 2009, 8:5541-5549.
29. Liu S., Zhang Y., Xie X., Hu W., Cai R., Kang J., et al. Application of two-dimensional electrophoresis in the research of retinal proteins of diabetic rat. Cell Mol Immunol 2007, 4:65-70.
30. Gao B.B., Chen X., Timothy N., Aiello L.P., Feener E.P. Characterization of the vitreous proteome in diabetes without diabetic retinopathy and diabetes with proliferative diabetic retinopathy. J Proteome Res 2008, 7:2516-2525.
31. Garcia-Ramirez M., Canals F., Hernandez C., Colome N., Ferrer C., Carrasco E., et al. Proteomic analysis of human vitreous fluid by fluorescence-based difference gel electrophoresis (DIGE): a new strategy for identifying potential candidates in the pathogenesis of proliferative diabetic retinopathy. Diabetologia 2007, 50:1294-1303.
32. Ouchi M., West K., Crabb J.W., Kinoshita S., Kamei M. Proteomic analysis of vitreous from diabetic macular edema. Exp Eye Res 2005, 81:176-182.
33. Simo R., Higuera M., Garcia-Ramirez M., Canals F., Garcia-Arumi J., Hernandez C. Elevation of apolipoprotein A-I and apolipoprotein H levels in the vitreous fluid and overexpression in the retina of diabetic patients. Arch Ophthalmol 2008, 126:1076-1081.
34. Thornit D.N., Vinten C.M., Sander B., Lund-Andersen H., La Cour M. Blood-retinal barrier glycerol permeability in diabetic macular edema and healthy eyes: estimations from macular volume changes after peroral glycerol. Invest Ophthalmol Vis Sci 2010, 51:2827-2834.
35. Hayreh S.S. The Cilio-Retinal Arteries. Br J Ophthalmol 1963, 47:71-89.
36. Barsotti M.F., Bartels S.P., Freddo T.F., Kamm R.D. The source of protein in the aqueous humor of the normal monkey eye. Invest Ophthalmol Vis Sci 1992, 33:581-595.
37. Maurice D.M. Flow of water between aqueous and vitreous compartments in the rabbit eye. Am J Physiol 1987, 252:F104-F108.
38. Fatt I. Flow and diffusion in the vitreous body of the eye. Bull Math Biol 1975, 37:85-90.
39. Gustafsson J.S., Ceasar R., Glasbey C.A., Blomberg A., Rudemo M. Statistical exploration of variation in quantitative two-dimensional gel electrophoresis data. Proteomics 2004, 4:3791-3799.
40. Carvajal-Rodriguez A., de Una-Alvarez J., Rolan-Alvarez E. A new multitest correction (SGoF) that increases its statistical power when increasing the number of tests. BMC Bioinformatics 2009, 10:209.
41. Diz A.P., Carvajal-Rodriguez A., Skibinski D.O. Multiple hypothesis testing in proteomics: a strategy for experimental work. Mol Cell Proteomics 2011, doi:10.1074/mcp.M110.004374.
42. Jha P., Das B.K., Shrestha S., Majhi S., Chandra L., Sharma S., et al. Glycemic status, lipid profile and proteinuria in diabetic nephropathy. JNMA J Nepal Med Assoc 2010, 49:143-146.
43. Fosmark D.S., Bragadottir R., Stene-Johansen I., Berg J.P., Berg T.J., Lund T., et al. Increased vitreous levels of hydroimidazolone in type 2 diabetes patients are associated with retinopathy: a case-control study. Acta Ophthalmol Scand 2007, 85:618-622.
44. Kato S., Oshika T., Funatsu H., Kokutei K., Yamashita H., Sawa M. Aqueous protein concentration in diabetics. Report 5. Relationship between aqueous protein concentration and pathological findings of iridial vessels. Nippon Ganka Gakkai Zasshi 1992, 96:1000-1006.
45. Schalnus R., Ohrloff C., Jungmann E., Maass K., Rinke S., Wagner A. Permeability of the blood-retinal barrier and the blood-aqueous barrier in type I diabetes without diabetic retinopathy: simultaneous evaluation with fluorophotometry. Ger J Ophthalmol 1993, 2:202-206.
46. Khuseyinova N., Koenig W. Apolipoprotein A-I and risk for cardiovascular diseases. Curr Atheroscler Rep 2006, 8:365-373.
47. Ponka P., Lok C.N. The transferrin receptor: role in health and disease. Int J Biochem Cell Biol 1999, 31:1111-1137.
48. Simo R., Garcia-Ramirez M., Higuera M., Hernandez C. Apolipoprotein A1 is overexpressed in the retina of diabetic patients. Am J Ophthalmol 2009, 147:319-325. e1.
49. Laicine E.M., Haddad A. Transferrin, one of the major vitreous proteins, is produced within the eye. Exp Eye Res 1994, 59:441-445.
50. Davidson M.G., Harned J., Grimes A.M., Duncan G., Wormstone I.M., McGahan M.C. Transferrin in after-cataract and as a survival factor for lens epithelium. Exp Eye Res 1998, 66:207-215.
51. Chauhan B.K., Disanza A., Choi S.Y., Faber S.C., Lou M., Beggs H.E., et al. Cdc42- and IRSp53-dependent contractile filopodia tether presumptive lens and retina to coordinate epithelial invagination. Development 2009, 136:3657-3667.
52. Boycott B.B., Hopkins J.M. A neurofibrillar method stains solitary (primary) cilia in the mammalian retina: their distribution and age-related changes. J Cell Sci 1984, 66:95-118.
53. Evans T., Deng D.X., Chen S., Chakrabarti S. Endothelin receptor blockade prevents augmented extracellular matrix component mRNA expression and capillary basement membrane thickening in the retina of diabetic and galactose-fed rats. Diabetes 2000, 49:662-666.
54. Vinores S.A., Van Niel E., Kim H.J., Campochiaro P.A. Simultaneous expression of keratin and glial fibrillary acidic protein by the same cells in epiretinal membranes. Invest Ophthalmol Vis Sci 1992, 33:3361-3366.
55. Didangelos A., Yin X., Mandal K., Baumert M., Jahangiri M., Mayr M. Proteomics characterization of extracellular space components in the human aorta. Mol Cell Proteomics 2010, 9:2048-2062.
56. Shimizu-Hirota R., Sasamura H., Kuroda M., Kobayashi E., Saruta T. Functional characterization of podocan, a member of a new class in the small leucine-rich repeat protein family. FEBS Lett 2004, 563:69-74.
57. Kardesler L., Biyikoglu B., Cetinkalp S., Pitkala M., Sorsa T., Buduneli N. Crevicular fluid matrix metalloproteinase-8, -13, and TIMP-1 levels in type 2 diabetics. Oral Dis 2010, 16:476-481.
58. Murdaca J., Treins C., Monthouel-Kartmann M.N., Pontier-Bres R., Kumar S., Van Obberghen E., et al. Grb10 prevents Nedd4-mediated vascular endothelial growth factor receptor-2 degradation. J Biol Chem 2004, 279:26754-26761.
59. Koh J.T., Kook H., Kee H.J., Seo Y.W., Jeong B.C., Lee J.H., et al. Extracellular fragment of brain-specific angiogenesis inhibitor 1 suppresses endothelial cell proliferation by blocking alphavbeta5 integrin. Exp Cell Res 2004, 294:172-184.
60. Yoon K.C., Ahn K.Y., Lee J.H., Chun B.J., Park S.W., Seo M.S., et al. Lipid-mediated delivery of brain-specific angiogenesis inhibitor 1 gene reduces corneal neovascularization in an in vivo rabbit model. Gene Ther 2005, 12:617-624.
61. Higuchi A., Takahashi K., Hirashima M., Kawakita T., Tsubota K. Selenoprotein P controls oxidative stress in cornea. PLoS One 2010, 5:e9911.
62. Steinbrenner H., Bilgic E., Alili L., Sies H., Brenneisen P. Selenoprotein P protects endothelial cells from oxidative damage by stimulation of glutathione peroxidase expression and activity. Free Radic Res 2006, 40:936-943.
63. Biermann J., Lagreze W.A., Schallner N., Schwer C.I., Goebel U. Inhalative preconditioning with hydrogen sulfide attenuated apoptosis after retinal ischemia/reperfusion injury. Mol Vis 2011, 17:1275-1286.